Kodiak Sciences is trading at $82.31, down 10.17%, amid broad market weakness following hotter-than-expected September CPI, which raised rate concerns and pressured growth stocks.
- No clear new company-specific announcement was identified for October 14; available market coverage also reported no new company-specific catalyst.
- The S&P 500 fell 1.32% and Nasdaq 2.08%; XBI was down 2.01%, reflecting biotech-sector pressure.
- These broader moves provide context, not proof of a single direct cause.